Equity markets in Europe have picked up from a very dismal 2023.
There is always robust interest in quality ASX /TSX /CSE listed companies with a dual-listing in Frankfurt. Especially where those companies have a sustainable purpose and vision, clear strategic direction with strong competitive advantage, capable board and management and unique value proposition. Stocks that see the greatest level of support are in the areas of critical raw materials, uranium, green metals and minerals, biotech and medtech, gold, clean energy and technology. ASX listed companies such as Droneshield (ASX: DRO) and Brainchip (ASX: BRN) see very solid support om German exchanges. We also see Australian companies with quality global projects in the areas of critical raw materials engage very strongly such as Winsome Resources (ASX: WIN) with a very strong lithium project in Canada. Uranium stocks in particular are trading very well this year in Germany such as Deep Yellow (ASX: DYL). 2024 has seen Novo Nordisk become the largest European company by market capitalisation and this has reignited interest in quality biotech and medtech stocks. The outlook continues to be bright for quality ASX / global companies to increase EU investor interest and engagement.
0 Comments
Leave a Reply. |
AuthorMatthew Reynolds. Archives
November 2024
Categories |